GNE-235: A Lead Compound Selective for the Second Bromodomain of PBRM1
Overview
Authors
Affiliations
Bromodomains are acetyl-lysine binding modules that are found in different classes of chromatin-interacting proteins. Among these are large chromatin remodeling complexes such as BAF and PBAF (variants of human SWI/SNF). Previous work has identified chemical probes targeting a subset of the bromodomains present in the BAF and PBAF complexes. Selective inhibitors of the individual bromodomains have proven challenging to discover, as the domains are highly similar. Here, elaboration of an aminopyridazine scaffold used previously to develop probes for the bromodomains of SMARCA2, SMARCA4, and the fifth bromodomain of PBRM1 yielded compounds with both potency and unusual selectivity for the second bromodomain of PBRM1. One of these, GNE-235, and its enantiomer control GNE-234 are suggested for initial cellular investigations of the function of the second bromodomain of PBRM1.
The Role of SWI/SNF Complex in Bladder Cancer.
Lei Z, Han Y, Liao J, Li X, Su Q, Yang Z J Cell Mol Med. 2025; 29(1):e70348.
PMID: 39779467 PMC: 11710939. DOI: 10.1111/jcmm.70348.
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.
Chen Y, Liang R, Li Y, Jiang L, Ma D, Luo Q Signal Transduct Target Ther. 2024; 9(1):340.
PMID: 39627201 PMC: 11615378. DOI: 10.1038/s41392-024-02030-9.
Epigenetics-targeted drugs: current paradigms and future challenges.
Dai W, Qiao X, Fang Y, Guo R, Bai P, Liu S Signal Transduct Target Ther. 2024; 9(1):332.
PMID: 39592582 PMC: 11627502. DOI: 10.1038/s41392-024-02039-0.
Chromatin remodellers as therapeutic targets.
Malone H, Roberts C Nat Rev Drug Discov. 2024; 23(9):661-681.
PMID: 39014081 PMC: 11534152. DOI: 10.1038/s41573-024-00978-5.
Targeting SWI/SNF Complexes in Cancer: Pharmacological Approaches and Implications.
Dreier M, Walia J, de la Serna I Epigenomes. 2024; 8(1).
PMID: 38390898 PMC: 10885108. DOI: 10.3390/epigenomes8010007.